Dose-response effect of depot leuprolide acetate on serum androgens In hirsute women

被引:6
|
作者
Rittmaster, RS [1 ]
Arab, DM [1 ]
Lehman, L [1 ]
机构
[1] DALHOUSIE UNIV,DEPT MED,HALIFAX,NS,CANADA
基金
英国医学研究理事会;
关键词
hirsutism; polycystic ovary syndrome; gonadotropin-releasing hormone agonist; leuprolide acetate; androgens; estrogen replacement;
D O I
10.1016/S0015-0282(16)58259-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the dose of leuprolide acetate (LA) needed to maximally suppress serum androgens in hirsute women. Design: Prospective, dose-escalation study. Setting: Outpatient endocrinology clinic. Patients: Eight hyperandrogenic women with moderate to severe hirsutism. Interventions: A LA dose-response study was done in women receiving depot LA plus estrogen-progestin replacement. Main Outcome Measures: Serum concentrations of T, androstenedione (A), and basal and GnRH-stimulated LH. Results: The lowest LA dose (3.75 mg/mo) suppressed serum T by 62% +/- 6% and A by 56% +/- 7%. No further decrease in serum androgens was seen with doses up to 15 mg/mo. Maximal suppression of basal and stimulated LH was also seen with the lowest dose of LA. Conclusions: As opposed to results previously published in children with precocious puberty, the 3.75 mg dose of depot LA is sufficient to maximally suppress serum androgens in hyperandrogenic women.
引用
收藏
页码:912 / 915
页数:4
相关论文
共 50 条
  • [31] DOSE-RESPONSE EVALUATION OF ANDROGENS IN TREATMENT OF METASTATIC BREAST-CANCER
    TALLEY, RW
    HAINES, CR
    WATERS, MN
    GOLDENBERG, IS
    OLSON, KB
    BISEL, HF
    CANCER, 1973, 32 (02) : 315 - 320
  • [32] Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating women
    Ratchanon, S
    Taneepanichskul, S
    OBSTETRICS AND GYNECOLOGY, 2000, 96 (06): : 926 - 928
  • [33] Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty
    Nael M. Mostafa
    Balakrishna Hosmane
    Lois M. Larsen
    Kristof Chwalisz
    Yi-Lin Chiu
    Rajendra S. Pradhan
    Clinical Drug Investigation, 2014, 34 : 441 - 448
  • [34] PROGNOSTIC VALUE OF THE EARLY SERUM ESTRADIOL RESPONSE TO LEUPROLIDE ACETATE IN INVITRO FERTILIZATION
    PADILLA, SL
    BAYATI, J
    GARCIA, JE
    FERTILITY AND STERILITY, 1990, 53 (02) : 288 - 294
  • [35] Dose-effect and dose-response relationship
    Bard, Denis
    Cerf, Olivier
    ENVIRONNEMENT RISQUES & SANTE, 2007, 6 (05): : 382 - 382
  • [36] EFFECT OF LEUPROLIDE ACETATE DEPOT ON THE GROWTH OF N-NITROSOMETHYLUREA-INDUCED RAT MAMMARY-TUMORS
    LORENZO, HK
    CAMPO, C
    PEREZLOPEZ, FR
    NEUROENDOCRINOLOGY LETTERS, 1991, 13 (02) : 83 - 88
  • [37] EFFECT OF CYPROTERONE-ACETATE ON PITUITARY-ADRENAL AXIS IN HIRSUTE WOMEN
    SMALS, AGH
    KLOPPENBORG, PWC
    GOVERDE, HJM
    BENRAAD, TJ
    ACTA ENDOCRINOLOGICA, 1978, 87 (02): : 352 - 358
  • [38] Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
    Vuralli, Dogus
    Alikasifoglu, Ayfer
    Iyigun, Irem
    Canoruc, Dicle
    Ozon, Alev
    Gonc, Nazli
    Kandemir, Nurgun
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2020, 12 (01) : 37 - 44
  • [39] Pharmacokinetic and Exposure-Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty
    Mostafa, Nael M.
    Hosmane, Balakrishna
    Larsen, Lois M.
    Chwalisz, Kristof
    Chiu, Yi-Lin
    Pradhan, Rajendra S.
    CLINICAL DRUG INVESTIGATION, 2014, 34 (07) : 441 - 448
  • [40] DEPOT LEUPROLIDE ACETATE VERSUS DANAZOL FOR TREATMENT OF PELVIC ENDOMETRIOSIS - CHANGES IN VERTEBRAL BONE MASS AND SERUM ESTRADIOL AND CALCITONIN
    DAWOOD, MY
    RAMOS, J
    KHANDAWOOD, FS
    FERTILITY AND STERILITY, 1995, 63 (06) : 1177 - 1183